Scientists develop robust iPSC-derived rejuvenated T lymphocytes for cervical cancer treatment

  • Post author:
  • Post category:uncategorized

Cervical cancer is among the most common malignancies affecting women worldwide. In 2020 alone, approximately 600,000 women were diagnosed with this disease, and over 314,000 died from it.